New perspectives on immunobiology and immunotherapy of melanoma
- 1 January 1999
- journal article
- trends
- Published by Elsevier in Immunology Today
- Vol. 20 (1) , 5-7
- https://doi.org/10.1016/s0167-5699(98)01373-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Licence to killNature, 1998
- A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cellNature, 1998
- Help for cytotoxic-T-cell responses is mediated by CD40 signallingNature, 1998
- T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactionsNature, 1998
- New Paths in Human Cancer SerologyThe Journal of Experimental Medicine, 1998
- Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γNature Medicine, 1998
- Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I studyGene Therapy, 1998
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaNature Medicine, 1998
- Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94BMJ, 1997
- Serological identification of human tumor antigensCurrent Opinion in Immunology, 1997